BIOZOL TRANSDERMAL SERUM Trademark

Trademark Overview

On Friday, January 27, 2017, a trademark application was filed for BIOZOL TRANSDERMAL SERUM with the United States Patent and Trademark Office. The USPTO has given the BIOZOL TRANSDERMAL SERUM trademark a serial number of 87316486. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Nuremedy Pharma LLC. The BIOZOL TRANSDERMAL SERUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical formulation for transcutaneous drug delivery for the treatment of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak, and poison sumac
biozol transdermal serum

General Information

Serial Number87316486
Word MarkBIOZOL TRANSDERMAL SERUM
Filing DateFriday, January 27, 2017
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6175489
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2017

Trademark Statements

Disclaimer with Predetermined Text"TRANSDERMAL SERUM"
Goods and ServicesPharmaceutical formulation for transcutaneous drug delivery for the treatment of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak, and poison sumac

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2017
Primary Code005
First Use Anywhere DateTuesday, August 18, 2020
First Use In Commerce DateTuesday, August 18, 2020

Trademark Owner History

Party NameNexzol Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNexzol Pharma, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNuremedy Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144
Party NameNuremedy Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Friday, September 11, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 10, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 24, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 18, 2020USE AMENDMENT FILED
Tuesday, August 18, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2020EXTENSION 5 GRANTED
Thursday, December 12, 2019EXTENSION 5 FILED
Thursday, December 12, 2019TEAS EXTENSION RECEIVED
Friday, July 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2019EXTENSION 4 GRANTED
Wednesday, July 24, 2019EXTENSION 4 FILED
Wednesday, July 24, 2019TEAS EXTENSION RECEIVED
Thursday, February 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 26, 2019EXTENSION 3 GRANTED
Tuesday, February 26, 2019EXTENSION 3 FILED
Tuesday, February 26, 2019TEAS EXTENSION RECEIVED
Monday, January 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 30, 2018EXTENSION 2 GRANTED
Thursday, August 23, 2018EXTENSION 2 FILED
Thursday, August 23, 2018TEAS EXTENSION RECEIVED
Saturday, May 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 4, 2018EXTENSION 1 GRANTED
Monday, February 5, 2018EXTENSION 1 FILED
Monday, March 5, 2018RESPONSE TO ITU OFFICE ACTION ENTERED
Monday, March 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 9, 2018ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Friday, February 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 5, 2018TEAS EXTENSION RECEIVED
Tuesday, August 29, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, April 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, April 24, 2017ASSIGNED TO EXAMINER
Tuesday, January 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 31, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

serum transdermal biozol poison infections pain inflammation fever joint dermatitis arthritis blisters cold